Physician profile
Joseph Devillier
NPI 1457857740
$4,578.11
in general payments reported to CMS, 2019-2025
31 companies · $1,508 in 2025
The $1,508 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $60.97 · 2022: $268 · 2023: $1,316 · 2024: $1,426 · 2025: $1,508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,249.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $742.17 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $628.03 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $623.09 | 2023-2025 | Breztri, Farxiga, Airsupra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $427.97 | 2023-2025 | Xifaxan, Trulance |
| Novo Nordisk INC | $237.81 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Abbott Laboratories | $232.89 | 2022-2025 | Freestyle Libre 3 |
| Abbvie INC. | $207.76 | 2023-2025 | Vraylar, Ubrelvy |
| Glaxosmithkline, LLC. | $178.35 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Inspire Medical Systems, INC. | $165.04 | 2023-2024 | Inspire |
| Exact Sciences Corporation | $162.11 | 2023-2025 | Cologuard Collection Kit |
| Mylan Specialty L.P. | $157.92 | 2022-2024 | Yupelri |
| Astellas Pharma US INC | $147.63 | 2023-2025 | Veozah |
| Novartis Pharmaceuticals Corporation | $93.73 | 2023-2024 | |
| Amgen INC. | $80.04 | 2023-2025 | Evenity, Repatha, Otezla |
| Axsome Therapeutics, INC. | $59.13 | 2025 | Auvelity |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $58.27 | 2025 | Voquezna |
| Merck Sharp & Dohme LLC | $57.70 | 2023 | Verquvo, Steglatro, Gardasil 9 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.69 | 2023-2025 | Jardiance, Tradjenta |
| Averitas Pharma INC. | $42.34 | 2024 | Qutenza |
| Dynavax Technologies Corporation | $34.05 | 2024 | Heplisav-B |
| Lantheus Medical Imaging, INC. | $31.95 | 2021 | |
| Atricure, INC. | $20.24 | 2024 | |
| Viiv Healthcare Company | $19.74 | 2025 | Apretude |
| Boston Scientific Corporation | $19.04 | 2022 | |
| Vbi Vaccine (Delaware) INC. | $17.31 | 2023 | Prehevbrio |
| Lundbeck LLC | $16.05 | 2025 | Rexulti |
| Amneal Pharmaceuticals LLC | $15.07 | 2025 | Unithroid |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.89 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.40 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $14.13 | 2021 | |
| Xeris Pharmaceuticals, INC. | $13.57 | 2025 | Gvoke Hypopen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Devillier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.